Accidental Ingestion of 25 mg Bonamine (Meclizine) in a 5-Year-Old
A single 25 mg meclizine tablet ingested by a 5-year-old is unlikely to cause serious toxicity but warrants immediate poison control consultation and close monitoring for anticholinergic effects and sedation.
Immediate Actions
Contact Poison Control
- Call your regional poison control center (1-800-222-1222) immediately for expert guidance on this specific exposure, as recommended for all pediatric medication ingestions 1.
- Provide the child's weight, exact time of ingestion, and any symptoms present.
Do Not Induce Vomiting
- Do not attempt to make the child vomit, as this is no longer recommended for home management of ingestions 1.
Expected Clinical Effects
Anticipated Symptoms
- Drowsiness and sedation are the most likely effects, as meclizine is an antihistamine with significant CNS depressant properties 2.
- Anticholinergic effects may occur, including:
- Dry mouth
- Urinary retention
- Blurred vision
- Confusion or agitation 2
- Symptoms typically appear within 1–4 hours of ingestion and may persist for 8–24 hours given meclizine's half-life of approximately 6–8 hours 3.
Severity Assessment
- The FDA-approved dosing for meclizine is not indicated for children under 12 years unless directed by a physician 2.
- A single 25 mg dose in a 5-year-old (typically weighing 15–20 kg) represents approximately 1.25–1.7 mg/kg, which is within the range studied in pediatric achondroplasia trials (12.5–25 mg daily) where no serious adverse events occurred 4, 3.
- Serious toxicity is uncommon with a single therapeutic-range dose, but individual sensitivity varies 5.
Monitoring at Home (If Poison Control Advises)
Observation Period
- Monitor the child closely for at least 6 hours after ingestion, as peak plasma concentration occurs around 1.7–3.7 hours 4, 3.
- Watch for progressive drowsiness, difficulty breathing, inability to wake, or seizures.
Red Flags Requiring Emergency Care
- Seek immediate emergency department evaluation if the child develops:
Emergency Department Management (If Indicated)
Gastrointestinal Decontamination
- Activated charcoal (1–2 g/kg orally or via nasogastric tube) may be considered if the child presents within 1–2 hours of ingestion and has a protected airway 1.
- Do not administer activated charcoal if the child is drowsy, vomiting, or at risk for aspiration 1.
- Charcoal efficacy declines rapidly after 1 hour but may provide some benefit up to 3–4 hours post-ingestion 1.
Supportive Care
- Ensure airway protection and have bag-mask ventilation equipment immediately available if sedation is significant 6.
- Provide intravenous fluids if the child is unable to maintain oral hydration.
- Monitor vital signs, including heart rate, blood pressure, respiratory rate, and oxygen saturation.
Antidote Considerations
- No specific antidote exists for meclizine overdose 2.
- Physostigmine (an anticholinesterase) is theoretically useful for severe anticholinergic toxicity but is rarely used in pediatric practice due to risks of bradycardia and seizures; consult a medical toxicologist before considering 7.
Key Clinical Pitfalls
Avoid Flumazenil
- Do not administer flumazenil for sedation, as meclizine is not a benzodiazepine and flumazenil has no role in antihistamine toxicity 7.
Avoid Routine Sorbitol
- If activated charcoal is given, use a non-sorbitol formulation in young children to prevent hypernatremic dehydration 1.
Drug Interactions
- If the child is taking sedatives, tranquilizers, or other CNS depressants, expect enhanced sedation and lower the threshold for emergency evaluation 2.